Business Standard

Tuesday, January 21, 2025 | 11:25 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Divis Laboratories

Divi's Laboratories shares slip 6% in trade; what's worrying investors?

The filing further said that the financials of the company won't be impacted and the penalty will be paid within the prescribed timeline

Divi's Laboratories shares slip 6% in trade; what's worrying investors?
Updated On : 05 Dec 2024 | 11:28 AM IST

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR

The PCR (Put Call Ratio) of these 3 stocks is above 1, implying presence of higher open positions in Puts as against Calls, shows the NSE options data.

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR
Updated On : 16 Oct 2024 | 11:44 AM IST

Divi's Lab, AEL, M&M among top movers & shakers in FY25; trading guide here

Among existing gainers, Divi's Lab and Shriram Finance seem poised for further gains, whereas losers IndusInd Bank and Nestle too look promising on technical charts; check key levels.

Divi's Lab, AEL, M&M among top movers & shakers in FY25; trading guide here
Updated On : 17 Sep 2024 | 1:38 PM IST

Divi's Labs shares jump 5% as US court stays FDA approval for Entresto drug

Shares of Divi's Laboratories surged up to 5 per cent at Rs 4960 per share on the BSE in Wednesday's intraday deals

Divi's Labs shares jump 5% as US court stays FDA approval for Entresto drug
Updated On : 21 Aug 2024 | 12:16 PM IST

BSE Healthcare hits new high; rallies 10% in 1 month on strong outlook

Solara Active Pharma Sciences, Indoco Remedies, Dishman Carbogen Amcis, Krishna Institute of Medical Sciences, Divi's Lab, Strides Pharma, Narayana Hrudayalaya and Vijaya Diagnostic were up 5 per cent

BSE Healthcare hits new high; rallies 10% in 1 month on strong outlook
Updated On : 21 Aug 2024 | 12:03 PM IST

Stock Market Highlights, Aug 5: Sensex tanks 2,223 points; Nifty ends near 24,050 amid global rout

Stock Market Live updates on August 5: Indian bourses are staring at a bear attack on Monday after heavy sell-off in global peers. The GIFT Nifty futures also indicated a gap-down start,

Stock Market Highlights, Aug 5: Sensex tanks 2,223 points; Nifty ends near 24,050 amid global rout
Updated On : 05 Aug 2024 | 4:11 PM IST

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts

Analysts say pharmaceutical company's stock fully priced in

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts
Updated On : 05 Aug 2024 | 3:59 PM IST

Rahul Gandhi stocks outperform; Nestle, Pidilite up 1% in a falling market

At 11:49 am; Nestle India (Rs 2,385.45), Pidilite Industries (Rs 2,988.45) and Divi's Labs (Rs 4,343.80) were trading higher by up to 1% higher, as compared to a near 5% decline in the BSE Sensex.

Rahul Gandhi stocks outperform; Nestle, Pidilite up 1% in a falling market
Updated On : 04 Jun 2024 | 12:21 PM IST

Buy ideas for May 30: Metro Brands, Divi's Labs; check target prices

Since April 2024, Metro Brands has been trading within a consolidation range of approximately Rs 1,020 to Rs 1,120

Buy ideas for May 30: Metro Brands, Divi's Labs; check target prices
Updated On : 30 May 2024 | 6:32 AM IST

Divi's Labs jumps 6% on stellar Q4; brokerages upgrade target prices

Divi's Labs net profits rose by 67 per cent to Rs 538 crore in the January-March quarter of FY24 compared to Rs 321 crore in the corresponding period last year

Divi's Labs jumps 6% on stellar Q4; brokerages upgrade target prices
Updated On : 27 May 2024 | 10:17 AM IST

Divi's Laboratories Q2FY24 result: Net profit dips 29% to Rs 348 crore

Divi's Labs Q2 result: The revenue from operations, however, rose 3 per cent to Rs 1,909 crore in the period from Rs 1,855 crore last year

Divi's Laboratories Q2FY24 result: Net profit dips 29% to Rs 348 crore
Updated On : 06 Nov 2023 | 1:35 PM IST

Divis Lab, Sun Pharma: Current breakout may lead Pharma index to new peak

Pharm index has broken out on upside, with the positive rally anticipated to hit 14,450

Divis Lab, Sun Pharma: Current breakout may lead Pharma index to new peak
Updated On : 03 Jul 2023 | 12:33 PM IST

RIL, Mphasis: 45 stocks hit fresh 52-week lows; charts show more pain ahead

The heavy-weight Reliance Industries has broken critical support of Rs 2,300, raising concerns about the future drawdown. In addition, the formation reveals a "Descending Triangle" violation

RIL, Mphasis: 45 stocks hit fresh 52-week lows; charts show more pain ahead
Updated On : 15 Mar 2023 | 11:35 AM IST

Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%
Updated On : 23 Dec 2022 | 12:19 PM IST

Divi's Lab Q2 net profit dips 18% to Rs 494 cr, revenue down to Rs 1,854 cr

Divi's Laboratories on Monday said its consolidated net profit declined by 18 per cent to Rs 494 crore in the second quarter of the current financial year. The drug firm had reported a net profit of Rs 606 crore in the July-September period of last fiscal. Revenue from operations declined to Rs 1,854 crore in the September quarter as against Rs 1,987 crore in the year-ago period. Shares of the company on Monday ended 8.63 per cent at Rs 3,422 apiece on the BSE.

Divi's Lab Q2 net profit dips 18% to Rs 494 cr, revenue down to Rs 1,854 cr
Updated On : 07 Nov 2022 | 4:39 PM IST

Divis Labs sheds 14% in two days, hits 52-week low post Q4 results

The company has earmarked an aggressive capex of around Rs 2,000 crore over next two years in order to take a chunk of around $20 billion opportunity of APIs going off-patent over FY23-25.

Divis Labs sheds 14% in two days, hits 52-week low post Q4 results
Updated On : 24 May 2022 | 10:02 AM IST

Divis Labs falls 9% on weak operational performance in September quarter

Ebitda margin contracted by 180 basis points year-on-year to 41.5 per cent in Q2FY22 due to higher other expenses/employee costs.

Divis Labs falls 9% on weak operational performance in September quarter
Updated On : 08 Nov 2021 | 10:17 AM IST

Divis Labs surges 10%, hits record high in Monday's session; here's why

Merck & Co's Covid-19 antiviral pill, Molnupiravir, reduced the risk of hospitalisation or death by 50 per cent

Divis Labs surges 10%, hits record high in Monday's session; here's why
Updated On : 04 Oct 2021 | 11:05 AM IST

Divi's Labs gains 3%, hits new high on strong March quarter results

The board has recommended a dividend of Rs 20 (i.e. 1,000 per cent) per equity share of face value Rs 2 each for the financial year 2020-21

Divi's Labs gains 3%, hits new high on strong March quarter results
Updated On : 31 May 2021 | 9:40 AM IST

Divi's Labs m-cap crosses Rs 1 trillion; stock zooms 109% in CY 2020 so far

Currently, Divis Labs stands at the 30th position among companies having market-cap of over Rs 1 trillion.

Divi's Labs m-cap crosses Rs 1 trillion; stock zooms 109% in CY 2020 so far
Updated On : 17 Dec 2020 | 10:58 AM IST